Page last updated: 2024-11-03

procainamide and CHARGE Association

procainamide has been researched along with CHARGE Association in 1 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Research Excerpts

ExcerptRelevanceReference
"CHARGE syndrome is an autosomal dominant congenital disorder caused primarily by mutations in the CHD7 gene."1.56Chemical screens in a zebrafish model of CHARGE syndrome identifies small molecules that ameliorate disease-like phenotypes in embryo. ( Asad, Z; Sachidanandan, C, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Asad, Z1
Sachidanandan, C1

Other Studies

1 other study available for procainamide and CHARGE Association

ArticleYear
Chemical screens in a zebrafish model of CHARGE syndrome identifies small molecules that ameliorate disease-like phenotypes in embryo.
    European journal of medical genetics, 2020, Volume: 63, Issue:2

    Topics: Animals; Animals, Genetically Modified; Cartilage; CHARGE Syndrome; Dipeptides; Disease Models, Anim

2020